期刊文献+

老年心肌梗死伴消化道出血患者临床特点的研究 被引量:10

The clinical characteristics of acute myocardial infarction patients with gastrointestinal bleeding in the elderly
原文传递
导出
摘要 目的分析老年急性心肌梗死(AMI)伴消化道出血患者的临床特点及预后。方法325例确诊为AMI的老年患者分为对照组(304例)、AMI后消化道出血组(14例)和消化道出血后AMI组(7例),分析老年AMI伴消化道出血患者的临床特点和1年心血管死亡和因再发心绞痛、非致死性AMI、心力衰竭和脑卒中而住院的复合终点结果。结果(1)AMI后消化道出血组的估测肾小球滤过率(eGFR)低于对照组,分别为(61.9±27.3)ml·min^-1·1.73m^-2与(77.3±27.9)ml·min^-1·1.73m^2,差异有统计学意义(P〈0.05),多因素回归分析结果显示,eGFR降低对老年AMI患者发生消化道出血的相对危险为0.980(95%CI为0.960~0.999,P(0.05);(2)消化道出血后AMI组抗血小板、抗凝治疗的比例和AMI后消化道出血组阿司匹林使用的比例均低于对照组(P均〈0.05),消化道出血后AMI组的血红蛋白低于AMI后消化道出血组,分别为(74±14)g/L与(111±25)g/L,差异有统计学意义(P〈0.01),接受输血治疗的比例高于AMI后消化道出血组,分别为85.7%(6例)与28.6%(4例),差异有统计学意义(P〈O.05);消化道出血后AMI组介入或溶栓治疗的比例显著低于对照组差异有统计学意义(P〈0.01);(3)AMI后消化道出血组的1年心血管死亡和因再发心绞痛、非致死性AMI、心力衰竭和脑卒中而住院的复合终点高于对照组,分别为42.9%(6/14)与17.8%(54/304),差异有统计学意义(P〈0.05)。结论eGFR降低是老年AMI患者发生消化道出血重要的预测因素。老年AMI患者伴发消化道出血常使抗血小板、抗凝和冠状动脉再通治疗困难,且多预后不良。 Objective To investigate the clinical characteristics and prognosis of acute myocardial infarction(AMI) patients with gastrointestinal bleeding (GIB) in the elderly. Methods Total 325 elderly patients with AMI were divided into AMI control group (n= 304, patients without gastrointestinal bleeding around the period of AMI), GIB-post-AMI (n= 14, patients developing gastrointestinal bleeding after AMI) group and AMI-post-GIB (n= 7, patients with gastrointestinal bleeding subsequently suffered an AMI) group. The clinical characteristics and combined end points of cardiovascular death and hospitalization for recurrent angina pectoris, non-lethal AMI, heart failure and stroke were analysed. Results (1) Estimated glomerular filtration rate (eGFR) became lower in the patients with GIB-post-MI (61.9 ± 27.3) ml·min^-1·1.73m^2compared with AMI control patients (77.3±27.9) ml·min^-1·1.73m^2,P〈0.05. Multivariate regression analysis revealed that the relative risk from a decreased eGFR for developing gastrointestinal bleeding after AMI in elderly patients was 0. 980 (95%CI: 0. 960-0. 999, P〈0.05). (2) There were significantly less patients adopting anti-platelet and anti-coagulant medications in AMI-post-GIB group and less patients applying aspirin in GIB-post-AMI group as compared with AMI control group, respectively (P〈0.05). AMI- post-GIB patients had significantly lower hemoglobin (74± 14) g/L than GIB-post-AMI patients (111 ±25) g/L, P〈0.01. More MI-post-GIB patients (6 cases, 85.7%) versus GIB-post-AMI patients (4 cases, 28.6%)underwent blood transfusion( P〈 0.05). There were significantly less patients adopting PCI and thrombolytic therapy in AMI-post-GIB group as compared to AMI control patients (P〈0.01). (3) The combined end points of cardiovascular death and hospitalization for recurrent angina pectoris, non-lethal MI, heart failure and stroke in GIB-post-MI group were significantly higher than in AMI control group [42.9% (6/14) vs. 17.8% (54/304), P〈0.05]. Conclusions Reduced eGFR is an important predictor for elderly AMI patients developing gastrointestinal bleeding which makes it difficult to take anti-platelet and anti-coagulant medication and to receive revascularization treatment, usually with worse prognosis.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2011年第10期823-826,共4页 Chinese Journal of Geriatrics
关键词 心肌梗死 胃肠出血 预后 Myocardial infarction Gastrointestinal hemorrhage Prognosis
  • 相关文献

参考文献9

  • 1EikelboomJW, Mehta SR, Anand SS, et al. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation, 2006, 114: 774-782.
  • 2高润霖.急性心肌梗死诊断和治疗指南[J].中华心血管病杂志,2001,29(12):710-725. 被引量:4974
  • 3Ma YC,Li Z, Chen JH, et al. Modified glomerular filtration rate estimating equation for chinese patients with chronic kidney disease. J Am Soc Nephrol, 2006, 17: 2937-2944.
  • 4Yan RT, Yan AT, Tan M, et al. For the Canadian Acute Coronary Syndromes ( ACS ) registry investigator, age related differences in the management and outcome of patients with acute coronary syndromes. Am Heart J, 2006, 151: 352-359.
  • 5Machowska A, Szlaeheie A, Pawlik M, et al. The role of female and male sex hormones in the healing process of preexisting lingual and gastric ulcerations. J Physiol Pharmacol, 2004, 55(Suppl. 2) : 91-104.
  • 6Moukarbel GV, Signorovitch JE, Pfeffer MA, et al. Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT Trial. Eur H J, 2009, 30:2226-2232.
  • 7Abraham NS, Hlatky MA, Antman EM, et al. ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. JACC, 2010, 56: 1-16.
  • 8Anderson JL, Adams CD, Antman EM, et al. ACC/ AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction., a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol, 2008, 50: e1-e157.
  • 9Rao SV, Jollis JG, Harrington RA, et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA, 2004, 292:1555-1562.

共引文献4973

同被引文献82

  • 1卞维静,张凌,谌贻璞,吕滨.血液透析患者冠状动脉电子束CT扫描钙化积分及其相关因素[J].中华肾脏病杂志,2005,21(2):65-68.
  • 2华琦,李东宝.低钾血症对急性心肌梗死患者预后的影响[J].中华老年心脑血管病杂志,2006,8(9):582-584. 被引量:25
  • 3姚菁,郑治渊,黄芸,张维,谈中茹,陈阳,邱朝晖,朱华.老年患者在冠脉支架术后长期联合运用阿司匹林和氯吡格雷的安全性及有效性的临床观察[J].老年医学与保健,2007,13(4):234-236. 被引量:5
  • 4中国食品药品监督局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:312-322.
  • 5de Waha S, Eitel I, Desch S, et al. Association of upstream clopidogrel administration and myocardial reperfusion assessed by cardiac magnetic resonance imaging in patients with ST-elevation myocardial infarction [J]. Eur Heart J Acute Cardiovasc Care, 2014, 3(2~: 110-117.
  • 6Komowski R, Mehran R, Dangas ~ et al. Prognostic impact of staged versus "one-time" multivessel percutaneousintervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial [J]. JAm Coil Cardiol, 2012, 59(4): 431-432.
  • 7Lu Y, Hajifathalian K, Rimm E B, et al. Mediators of the effect of body mass index on coronary heart disease: decomposing direct and indirect effects [J]. Epidemiol, 2015, 26(2): 153-162.
  • 8Halbritter K, Beyer-Westendorf J, Nowotny J, et al. Hospitalization for vitamin-K-antagonist-related bleeding: treatment patterns and outcome[J]. J Thmmb Haemost, 2013, 11(4): 651-659.
  • 9Cho KH, Jeong MH, Ahmed K,et al. Value of early risk stratification using hemoglobin level and neutrophil-to- lymphocyte ratio in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary in- tervention [ J ] Am J Cardio1,2011,107 ( 6 ) :849 - 856.
  • 10Kose M, Emet S, Akpinar TS, et al. Serum endoean level and the severity of coronary artery disease: a pilot study[ J]. Angiology,2015,66( 8 ) :727 - 731.

引证文献10

二级引证文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部